Written by:
Fiona Lewis, Advocacy Associate, ACRO
When we think about rural health and the needs of rural communities, we often think of needing to expand access to healthcare providers, address hospital closures, and enhance maternal health services, for example. However, public health initiatives tend to overlook a critical component of healthcare access: clinical trials. Rural communities face significant disparities to clinical trial recruitment, including limited knowledge and awareness of trial opportunities (on both the participant and provider sides), financial hardships that hinder participation, and travel burdens, to name a few.[1] When clinical trial sites are located far from a participant’s home, they must contend not only with the distance but also with the financial and logistical burdens of travel, including needing to take off work, forfeiting wages, and hiring childcare. Limited awareness and understanding of clinical trials can leave prospective participants fearful or confused and unwilling to participate. Together, these challenges create significant barriers for rural participants, increasing the risk that they will be under-recruited and underrepresented in clinical trials.[2]
So, how can the clinical research industry capitalize on ongoing rural health advocacy efforts to expand opportunities for clinical trial integration in rural communities?

Investing in Community-Based Sites to Expand Rural Access
This National Rural Health Day, which celebrates rural healthcare providers, organizations, and communities, ACRO reflects the ongoing efforts of community clinical trial sites to bring clinical research opportunities to more patients in rural areas. Most recently, ACRO took a deep dive into the challenges facing rural community clinical trial sites, including limited industry funding, a lack of community education and awareness, distrust of the healthcare system, infrastructure barriers, site capacity, and the costs of travel and participation. To help address these challenges, ACRO launched its Site Resource Grant Program, providing grants of $25,000-$50,000 to seven trial sites nationwide over 12 months. This funding gave sites the flexibility to develop creative approaches to diversifying patient enrollment beyond the trial-specific funding typically provided through sponsor contracts, rather than focusing on broader site infrastructure improvements.
In determining grant recipients, ACRO prioritized the inclusion of rural sites, recognizing the significant barriers these communities and patients face in accessing healthcare opportunities. Two grant recipients, Nebraska Cancer Specialists and Superior Clinical Research, both focused on addressing these challenges in their respective communities.
Nebraska Cancer Specialists sought to address the difficulties that their sites faced in reaching patients due to weak referral networks and low awareness of clinical trials outside of academic medical centers. In response, staff used grant funds to strengthen these referral pathways, connecting community members with physicians directly involved in trials. They also developed new educational materials and opportunities, including videos explaining the benefits of trial participation, answering frequently asked questions about the clinical research process, and hosting “Lunch and Learn” sessions with local medical practices to educate providers on trial opportunities and existing referral networks. Together, these initiatives addressed systemic barriers to rural healthcare access, including awareness, access, and trust. They helped connect rural Nebraskans with clinical trial opportunities while strengthening collaboration among community health resources. The results were significant: Nebraska Cancer Specialists showed a 420% increase in patients referred to oncology trials and a 33% increase in trial enrollment.
Similarly, Superior Clinical Research, located in Smithville, North Carolina, used its grant funding to integrate clinical trial opportunities into their rural community through local outreach initiatives. By hosting community-centric events including health and wellness fairs, “Lunch and Learn” sessions, and clinical site open houses, Superior Clinical Research delivered healthcare services and raised awareness of trials among its primary patient populations: racial and ethnic minorities, women, and people living in medically underserved areas. These efforts demonstrated the value of integrating care directly into the community, making clinical trial education more accessible, and engaging through events that meet their needs and foster meaningful connections. Superior Clinical Research’s community-centered initiatives yielded a measurable increase in community engagement and participation, with a 46% increase in patients screened and a 44% increase in patients enrolled in their trials.
Building on Momentum: Four Priorities for Expanding Rural Clinical Trial Access
ACRO’s Site Resource Grant Program is only the beginning. To expand clinical trial access in rural communities, the clinical research industry must:
- Invest in community-based trial sites and strengthen connections with rural patients.
- Emphasize rural clinical trial access to discussions with policymakers and advocate for policies that help reduce existing barriers.
- Address the social determinants of health when evaluating clinical trial access, recognizing geography as a pain point in trial access.
- Build trust in medically underserved rural communities by meeting patients where they are and tailoring outreach to their needs and interests.
Aligning Industry and Policy Efforts to Advance Rural Clinical Research
Policymakers have increasingly championed efforts to connect rural populations with essential healthcare services and clinical trial opportunities. These efforts include direct approaches such as the Faster Clinical Trials Act, which will prioritize rural clinics via its Cures in Care Initiative,[3] and Clinical Trial Modernization Act, and broader initiatives, like the Rural Health Transformation Program. The clinical research industry must build on this momentum by leveraging its role in connecting patients with opportunities to participate in clinical trials and engaging with the current policy environment. Together, sponsors, sites, and industry stakeholders, like ACRO and its members, can build clinical trials that better serve rural patients and advance a more sustainable, representative, and accessible clinical trial ecosystem.
References
- Ruhi Thaper et al, “Barriers and facilitators to recruitment of rural patients to cancer clinical trials,” Baylor University Medical Center Proceedings, 2025 https://pmc.ncbi.nlm.nih.gov/articles/PMC12671508/#CIT0005
- Ruhi Thaper et al, “Barriers and facilitators to recruitment of rural patients to cancer clinical trials,” Baylor University Medical Center Proceedings, 2025 https://pmc.ncbi.nlm.nih.gov/articles/PMC12671508/#CIT0005
- Auchincloss, Griffith Introduce Faster Clinical Trials Act,” US House of Representatives, October 22, 2026, https://auchincloss.house.gov/media/press-releases/auchincloss-griffith-introduce-faster-clinical-trials-act; “Chairman Griffith Helps Lead Effort To Revamp Rural Patient Access to Clinical Trials, Accelerate New Treatments to Market,” US House of Representatives, October 22, 2026, https://morgangriffith.house.gov/news/documentsingle.aspx?DocumentID=405855
